The price of Zoryve (roflumilast) cream varies depending on the pharmacy and insurance coverage. Some sources indicate a retail price of approximately $1,046.60 for a 60-gram tube [1]. However, out-of-pocket costs can be significantly lower with coupons or patient assistance programs.
What helps reduce the cost of Zoryve cream?
Patient assistance programs and savings cards can substantially lower the out-of-pocket expenses for Zoryve cream. For eligible commercially insured patients, savings cards may reduce the cost to as little as $25 per prescription, with a maximum savings of $150 per fill and $600 annually [2]. Those without insurance or who have government insurance may not be eligible for these savings programs.
Where can I find Zoryve cream discounts?
Discounts and savings information for Zoryve cream are often available through the manufacturer's website or co-pay assistance program portals. For example, a Zoryve Savings Card is advertised, which could bring the cost down to $25 for eligible patients [3].
How does Zoryve cream work?
Zoryve cream contains the active ingredient roflumilast, which is a phosphodiesterase 4 (PDE4) inhibitor [4]. PDE4 is an enzyme found in inflammatory cells. By inhibiting PDE4, roflumilast reduces the release of inflammatory mediators, thereby helping to manage inflammation associated with certain skin conditions [4].
What conditions is Zoryve cream used to treat?
Zoryve cream is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and older [5].
When does the patent for Zoryve expire?
Information regarding the specific patent expiry dates for Zoryve (roflumilast) is not readily available in the provided context. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity [6].
Are there alternatives to Zoryve cream?
Several other topical treatments are available for plaque psoriasis, including corticosteroids, vitamin D analogues, and other PDE4 inhibitors. The choice of treatment often depends on the severity of the condition, patient preferences, and physician recommendations.